St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...

A joint research team from the Institute of Metal Research (IMR) of the Chinese Academy of Sciences and the Songshan Lake Materials Laboratory has achieved precise control and real-time observation of ...

Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics hence call for means ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

Announcing a new article publication for BIO Integration journal. Hepatic perivascular epithelioid cell tumor (PEComa) is a ...

Personalised healthcare is both the future and the present, says James Goolnik – and diagnostics, he argues, are the key to ...

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Despite the long-standing reputation of each, as well as distinct underlying physics, laser speckle contrast imaging (LSCI) and imaging photoplethysmography (IPPG) reach concordance on functional ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...

MARS Bioimaging, a New Zealand–headquartered medical device company specialising in portable spectral photon-counting CT ...

SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...